Therapeutic targets in systemic sclerosis

por Denton, Christopher P
Publicado 2007

Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis

por Denton, Christopher P., Murray, Charles
Publicado 2019

Pathogenesis of systemic sclerosis associated interstitial lung disease

por Nihtyanova, Svetlana I, Denton, Christopher P
Publicado 2020

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis

por Cole, Alice, Ong, Voon H., Denton, Christopher P.
Publicado 2022

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

por Herrick, Ariane L., Assassi, Shervin, Denton, Christopher P.
Publicado 2022

Sixth International Workshop on Scleroderma Research, Oxford, UK, 30 July–2 August 2000

por Wollheim, Frank A, Denton, Christopher P, Abraham, David J
Publicado 2001

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

por Gilbane, Adrian J, Denton, Christopher P, Holmes, Alan M
Publicado 2013

Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin

por Nikitorowicz-Buniak, Joanna, Denton, Christopher P., Abraham, David, Stratton, Richard
Publicado 2015

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats

por Tornling, Göran, Batta, Rohit, Salvail, Dan, Raud, Johan, Denton, Christopher P.
Publicado 2023

Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis

por Denton, Christopher P., Laird, Bee, Moros, Lizette, Flores, Jose Luis Luna
Publicado 2020

Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals—a discourse analysis

por Denton, Christopher P., Laird, Bee, Moros, Lizette, Luna Flores, Jose Luis
Publicado 2020

Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic

por Teles, Carolina, Liyanage, Chiranthi Kongala, Chow, Geoffrey, Denton, Christopher P, Ong, Voon
Publicado 2023

Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease

por Rubin, Lewis J, Black, Carol M, Denton, Christopher P, Seibold, James R
Publicado 2007

Systemic sclerosis and related connective tissue diseases: present and future

por Rubin, Lewis J, Black, Carol M, Denton, Christopher P, Seibold, James R
Publicado 2007

Pericytes display increased CCN2 expression upon culturing

por Shiwen, Xu, Rajkumar, Vineeth, Denton, Christopher P., Leask, Andrew, Abraham, David J.
Publicado 2009

STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiatio...

por Papaioannou, Ioannis, Xu, Shiwen, Denton, Christopher P., Abraham, David J., Ponticos, Markella
Publicado 2018

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon

por Kundu, Devi, Abraham, David, Black, Carol M., Denton, Christopher P., Bruckdorfer, K. Richard
Publicado 2014

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis

por Caetano, Joana, Nihtyanova, Svetlana I, Harvey, Jennifer, Denton, Christopher P, Ong, Voon H
Publicado 2018

Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins

por Stern, Edward P, Unwin, Robert, Burns, Aine, Ong, Voon H, Denton, Christopher P
Publicado 2021

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic

por Denton, Christopher P, Campochiaro, Corrado, Bruni, Cosimo, Distler, Oliver, Iagnocco, Annamaria, Matucci Cerinic, Marco
Publicado 2020